Document Classification

Section Type: RESULTS

Text: Compared with placebo, the use of spironolactone resulted in significant improvements in left ventricular mass (-14 + / - 13 g vs. +3 + / - 11 g, p < 0. 01), pulse wave velocity (-0. 8 + / - 1. 0 m/s vs. -0. 1 + / - 0. 9 m/s, p < 0. 01), augmentation index (-5. 2 + / - 6. 1 % vs. -1. 4 + / - 5. 9 %, p < 0. 05), and aortic distensibility (0. 69 + / - 0. 86 x 10 (-3) mm Hg vs. 0. 04 + / - 1. 04 x 10 (-3) mm Hg, p < 0. 01).